Structure-activity relationships of chromogranin A in cell adhesion - Identification of an adhesion site for fibroblasts and smooth muscle cells

被引:68
作者
Ratti, S
Curnis, F
Longhi, R
Colombo, B
Gasparri, A
Magni, F
Manera, E
Metz-Boutigue, MH
Corti, A
机构
[1] San Raffaele Sci Inst, Dept Biol & Technol Res, I-20132 Milan, Italy
[2] CNR, IRBM, I-20132 Milan, Italy
[3] INSERM, Unite Biol Commun Cellulaire 338, F-67084 Strasbourg, France
关键词
D O I
10.1074/jbc.M003796200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previous studies showed that chromogranin A (CgA), a glycoprotein stored and co-released with various hormones by neuroendocrine cells and neurons, can modulate cell adhesion. We have investigated the structure-activity relationships of CgA using fibroblasts and coronary artery smooth muscle cells in adhesion assays. A recombinant CgA fragment 1-78 and a peptide 7-57 containing reduced and alkylated cysteines (Cys(17) and Cys(38)) induced cell adhesion after adsorption onto solid phases at 50-100 nM. Peptides lacking the disulfide loop region, including residues 47-68, 39-59, and 39-68, induced cell adhesion, either bound to solid phases at 200-400 nM or added to the liquid phase at 5-10 mu M, whereas peptide 60-68 was inactive, suggesting that residues 47-57 are important for activity. The effect of CgA-(1-78) was blocked by anti-CgA antibodies against epitopes including residues Arg(53), His(54), and Leu(57). Substitutions of residues His(54) Gln(55), and Asn(56) with alanine decreased the cell adhesion activity of peptide 47-68. These results suggest that the region 47-57 (RILSILRHQNL) contains a cell adhesion site and that the disulfide bridge is not necessary for the proadhesive activity. The ability of soluble peptides to elicit proadhesive effects suggests an indirect mechanism. The high sequence conservation and accessibility to antibodies suggest that this region is important for the physiological role of CgA.
引用
收藏
页码:29257 / 29263
页数:7
相关论文
共 40 条
[1]   VASOSTATINS, COMPRISING THE N-TERMINAL DOMAIN OF CHROMOGRANIN-A, SUPPRESS TENSION IN ISOLATED HUMAN BLOOD-VESSEL SEGMENTS [J].
AARDAL, S ;
HELLE, KB ;
ELSAYED, S ;
REED, RK ;
SERCKHANSSEN, G .
JOURNAL OF NEUROENDOCRINOLOGY, 1993, 5 (04) :405-412
[2]   THE VASOINHIBITORY ACTIVITY OF BOVINE CHROMOGRANIN-A FRAGMENT (VASOSTATIN) AND ITS INDEPENDENCE OF EXTRACELLULAR CALCIUM IN ISOLATED SEGMENTS OF HUMAN BLOOD-VESSELS [J].
AARDAL, S ;
HELLE, KB .
REGULATORY PEPTIDES, 1992, 41 (01) :9-18
[3]  
Blobel Carl P., 1992, Current Opinion in Cell Biology, V4, P760
[4]  
BRANDT DW, 1994, P SOC EXP BIOL MED, V205, P316
[5]   Chromogranin A induces a neurotoxic phenotype in brain microglial cells [J].
Ciesielski-Treska, J ;
Ulrich, G ;
Taupenot, L ;
Chasserot-Golaz, S ;
Corti, A ;
Aunis, D ;
Bader, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (23) :14339-14346
[6]  
Corti A, 1998, CANCER RES, V58, P3866
[7]   Production and structure characterisation of recombinant chromogranin A N-terminal fragments (vasostatins) - Evidence of dimer-monomer equilibria [J].
Corti, A ;
Sanchez, LP ;
Gasparri, A ;
Curnis, F ;
Longhi, R ;
Brandazza, A ;
Siccardi, AG ;
Sidoli, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 248 (03) :692-699
[8]   Antigenic regions of human chromogranin A and their topographic relationships with structural functional domains [J].
Corti, A ;
Longhi, R ;
Gasparri, A ;
Chen, FX ;
Pelagi, M ;
Siccardi, AG .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 235 (1-2) :275-280
[9]   Characterisation of circulating chromogranin A in human cancer patients [J].
Corti, A ;
Gasparri, A ;
Chen, FX ;
Pelagi, M ;
Brandazza, A ;
Sidoli, A ;
Siccardi, AG .
BRITISH JOURNAL OF CANCER, 1996, 73 (08) :924-932
[10]   DISTINCT PATTERNS OF CHROMOGRANIN-A-RELATED SPECIES CAN BE DEMONSTRATED IN ENDOCRINE-CELLS [J].
DEFTOS, LJ ;
GAZDAR, AF ;
HOGUEANGELETTI, R ;
MULLEN, PS ;
BURTON, DW .
BONE AND MINERAL, 1990, 9 (03) :169-178